ARID1A and pancreatic neoplasm: These genetically engineered mouse model (GEMM) data, plus the high prevalence of ARID1A/RNF43 mutations in our cohort and other PDAC cohorts,10, 24 established that these two genes were bona fide tumor suppressor genes for pancreatic cancer.